1887

Abstract

Kaposi's sarcoma-associated herpesvirus (KSHV) is a human gammaherpesvirus related to Epstein–Barr virus (EBV) and herpesvirus saimiri. KSHV open reading frame K8 encodes a basic region-leucine zipper protein of 237 aa that homodimerizes. K8 shows significant similarity to the EBV immediate-early protein Zta, a key regulator of EBV reactivation and replication. In this study, a carboxyl-terminal deletion mutant of K8, K8(1–115), that had strong transactivating properties was found. Screening using transcriptionally inactive K8(1–75) showed that K8 interacts and co-localizes with hSNF5, a cellular chromatin-remodelling factor, both and . This interaction requires aa 48–183 of hSNF5 and 1–75 of K8. In a yeast expression system, the ability of K8 and K8(1–115) to activate transcription requires the presence of SNF5, the yeast homologue of hSNF5. These data suggest a mechanism by which the SWI–SNF complex is recruited to specific genes. They also suggest that K8 functions as a transcriptional activator under specific conditions and that its transactivation activity requires its interaction with the cellular chromatin remodelling factor hSNF5.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/vir.0.18699-0
2003-03-01
2020-07-13
Loading full text...

Full text loading...

/deliver/fulltext/jgv/84/3/vir840665.html?itemId=/content/journal/jgv/10.1099/vir.0.18699-0&mimeType=html&fmt=ahah

References

  1. Adamson A. L., Kenney S.. 2001; Epstein–Barr virus immediate-early protein BZLF1 is SUMO-1 modified and disrupts promyelocytic leukemia bodies. J Virol75:2388–2399
    [Google Scholar]
  2. Arany Z., Newsome D., Oldread E., Livingston D. M., Eckner R.. 1995; A family of transcriptional adaptor proteins targeted by the E1A oncoprotein. Nature374:81–84
    [Google Scholar]
  3. Bell P., Lieberman P. M., Maul G. G.. 2000; Lytic but not latent replication of Epstein–Barr virus is associated with PML and induces sequential release of nuclear domain 10 proteins. J Virol74:11800–11810
    [Google Scholar]
  4. Blattner W. A.. 1999; Human retroviruses: their role in cancer. Proc Assoc Am Physicians111:563–572
    [Google Scholar]
  5. Boshoff C., Weiss R. A.. 1998; Kaposi's sarcoma-associated herpesvirus. Adv Cancer Res75:57–86
    [Google Scholar]
  6. Boshoff C., Schulz T. F., Kennedy M. M., Graham A. K., Fisher C., Thomas A., McGee J. O., Weiss R. A., O'Leary J. J.. 1995; Kaposi's sarcoma-associated herpesvirus infects endothelial and spindle cells. Nat Med1:1274–1278
    [Google Scholar]
  7. Cesarman E., Chang Y., Moore P. S., Said J. W., Knowles D. M.. 1995; Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas. N Engl J Med332:1186–1191
    [Google Scholar]
  8. Cheng S.-W. G., Davies K. P., Yung E., Beltran R. J., Yu J., Kalpana G. V.. 1999; c-Myc interacts with INI1/hSNF5 and requires the SWI/SNF complex for transactivation function. Nat Genet22:102–105
    [Google Scholar]
  9. Dorsman J. C., Teunisse A. F., Zantema A., van der Eb A. J.. 1997; The adenovirus 12 E1A proteins can bind directly to proteins of the p300 transcription co-activator family, including the CREB-binding protein CBP and p300. J Gen Virol78:423–426
    [Google Scholar]
  10. Eckner R., Ludlow J. W., Lill N. L., Oldread E., Arany Z., Modjtahedi N., DeCaprio J. A., Livingston D. M., Morgan J. A.. 1996; Association of p300 and CBP with simian virus 40 large T antigen. Mol Cell Biol16:3454–3464
    [Google Scholar]
  11. Fortunato E. A., Spector D. H.. 1998; p53 and RPA are sequestered in viral replication centers in the nuclei of cells infected with human cytomegalovirus. J Virol72:2033–2039
    [Google Scholar]
  12. Graham F. L., van der Eb A. J.. 1973; A new technique for the assay of infectivity of human adenovirus 5 DNA. Virology52:456–467
    [Google Scholar]
  13. Grand F., Kulkarni S., Chase A., Goldman J. M., Gordon M., Cross N. C. P.. 1999; Frequent deletion of hSNF5/INI1, a component of the SWI/SNF complex, in chronic myeloid leukemia. Cancer Res59:3870–3874
    [Google Scholar]
  14. Gruffat H., Portes-Sentis S., Sergeant A., Manet E.. 1999; Kaposi's sarcoma-associated herpesvirus (human herpesvirus-8) encodes a homologue of the Epstein–Barr virus bZip protein EB1. J Gen Virol80:557–561
    [Google Scholar]
  15. Guarante L.. 1983; Promoters and lacZ fusions designed to study expression of cloned genes in yeast. Methods Enzymol101:181–193
    [Google Scholar]
  16. Gwack Y., Byun H., Hwang S., Lim C., Choe J.. 2001; CREB-binding protein and histone deacetylase regulate the transcriptional activity of Kaposi's sarcoma-associated herpesvirus open reading frame 50. J Virol75:1909–1917
    [Google Scholar]
  17. Hwang S., Gwack Y., Byun H., Lim C., Choe J.. 2001; The Kaposi's sarcoma-associated herpesvirus K8 protein interacts with CREB-binding protein (CBP) and represses CBP-mediated transcription. J Virol75:9509–9516
    [Google Scholar]
  18. Kalpana G. V., Marmon S., Wang S., Crabtree G. R., Goff S. P.. 1994; Binding and stimulation of HIV-1 integrase by a human homolog of yeast transcription factor SNF5. Science266:2002–2006
    [Google Scholar]
  19. Katano H., Ogawa-Goto K., Hasegawa H., Kurata T., Sata T.. 2001; Human-herpesvirus-8-encoded K8 protein colocalizes with the promyelocytic leukemia protein (PML) bodies and recruits p53 to the PML bodies. Virology286:446–455
    [Google Scholar]
  20. Klochendler-Yeivin A., Fiette L., Barra J., Muchardt C., Babinet C., Yaniv M.. 2000; The murine SNF5/INI1 chromatin remodeling factor is essential for embryonic development and tumor suppression. EMBO Rep1:500–506
    [Google Scholar]
  21. Kornberg R. D., Lorch Y.. 1999; Twenty-five years of the nucleosome, fundamental particle of the eukaryote chromosome. Cell98:285–294
    [Google Scholar]
  22. Kowenz-Leutz E., Leutz A.. 1999; A C/EBPβ isoform recruits the SWI/SNF complex to activate myeloid genes. Mol Cell4:735–743
    [Google Scholar]
  23. Kowenz-Leutz E., Twamley G., Ansieau S., Leutz A.. 1994; Novel mechanism of C/EBPβ (NF-M) transcriptional control: activation through derepression. Genes Dev8:2781–2791
    [Google Scholar]
  24. Laurent B. C., Carlson M.. 1992; Yeast SNF2/SWI2, SNF5, and SNF6 proteins function coordinately with the gene-specific transcriptional activators GAL4 and Bicoid. Genes Dev6:1707–1715
    [Google Scholar]
  25. Laurent B. C., Treitel M. A., Carlson M.. 1990; The SNF5 protein of Saccharomyces cerevisiae is a glutamine- and proline-rich transcriptional activator that affects expression of a broad spectrum of genes. Mol Cell Biol10:5616–5625
    [Google Scholar]
  26. Lee D., Sohn H., Kalpana G. V., Choe J.. 1999; Interaction of E1 and hSNF5 proteins stimulate replication of human papillomavirus DNA. Nature399:487–491
    [Google Scholar]
  27. Lee D., Kim J. W., Seo T., Hwang S. G., Choi E. J., Choe J.. 2002; SWI/SNF complex interacts with tumor suppressor p53 and is necessary for the activation of p53-mediated transcription. J Biol Chem277:22330–22337
    [Google Scholar]
  28. Lin C. L., Yuan Y.. 2001; Expression pattern and DNA-binding property of KSHV ORF K8. 4th International Workshop on KSHV and Related Agents (California, USA: 5–8 August, 2001
    [Google Scholar]
  29. Lin S. F., Robinson D. R., Miller G., Kung H. J.. 1999; Kaposi's sarcoma-associated herpesvirus encodes a bZIP protein with homology to BZLF1 of Epstein–Barr virus. J Virol73:1909–1917
    [Google Scholar]
  30. Lukac D. M., Renne R., Kirshner J. R., Ganem D.. 1998; Reactivation of Kaposi's sarcoma-associated herpesvirus infection from latency by expression of the ORF 50 transactivator, a homolog of the EBV R protein. Virology252:304–312
    [Google Scholar]
  31. Miller G., Heston L., Grogan E.. 7 other authors 1997; Selective switch between latency and lytic replication of Kaposi's sarcoma herpesvirus and Epstein–Barr virus in dually infected body cavity lymphoma cells. J Virol71:314–324
    [Google Scholar]
  32. Morozov A., Yung E., Kalpana G. V.. 1998; Structure-function analysis of integrase interactor 1/hSNF5L1 reveals differential properties of two repeat motifs present in the highly conserved region. Proc Natl Acad Sci U S A95:1120–1125
    [Google Scholar]
  33. Muchardt C., Yaniv M.. 1999; The mammalian SWI/SNF complex and the control of cell growth. Semin Cell Dev Biol10:189–195
    [Google Scholar]
  34. Muchardt C., Yaniv M.. 2001; When the SWI/SNF complex remodels the cell cycle. Oncogene20:3067–3075
    [Google Scholar]
  35. Park J., Seo T., Hwang S., Lee D., Gwack Y., Choe J.. 2000; The K-bZIP protein from Kaposi's sarcoma-associated herpesvirus interacts with p53 and represses its transcriptional activity. J Virol74:11977–11982
    [Google Scholar]
  36. Peterson C. L., Herskowitz I.. 1992; Characterization of the yeast SWI1, SWI2, and SWI3 genes, which encode a global activator of transcription. Cell68:573–583
    [Google Scholar]
  37. Polson A. G., Huang L., Lukac D. M., Blethrow J. D., Morgan D. O., Burlingame A. L., Ganem D.. 2001; Kaposi's sarcoma-associated herpesvirus K-bZIP protein is phosphorylated by cyclin-dependent kinases. J Virol75:3175–3184
    [Google Scholar]
  38. Portes-Sentis S., Manet E., Gourru G., Sergeant A., Gruffat H.. 2001; Identification of a short amino acid sequence essential for efficient nuclear targeting of the Kaposi's sarcoma-associated herpesvirus/human herpesvirus-8 K8 protein. J Gen Virol82:507–512
    [Google Scholar]
  39. Reitz M. S. Jr, Nerurkar L. S., Gallo R. C.. 1999; Perspective on Kaposi's sarcoma: facts, concepts, and conjectures. J Natl Cancer Inst91:1453–1458
    [Google Scholar]
  40. Renne R., Zhong W., Herndier B., McGrath M., Abbey N., Kedes D., Ganem D.. 1996; Lytic growth of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) in culture. Nat Med2:342–346
    [Google Scholar]
  41. Rozenblatt-Rosen O., Rozovskaia T., Burakov D.. 7 other authors 1998; The C-terminal SET domains of ALL-1 and TRITHORAX interact with the INI1 and SNR1 proteins, components of the SWI/SNF complex. Proc Natl Acad Sci U S A95:4152–4157
    [Google Scholar]
  42. Russo J. J., Bohenzky R. A., Chien M. C.. 8 other authors 1996; Nucleotide sequence of the Kaposi sarcoma-associated herpesvirus (HHV8). Proc Natl Acad Sci U S A93:14862–14867
    [Google Scholar]
  43. Schulz T. F.. 1998; Kaposi's sarcoma-associated herpesvirus (human herpesvirus-8). J Gen Virol79:1573–1591
    [Google Scholar]
  44. Sevenet N., Lellouch-Tubiana A., Schofield D., Hoang-Xuan K., Gessler M., Birnbaum D., Jeanpierre C., Jouvet A., Delattre O.. 1999a; Spectrum of hSNF5/INI1 somatic mutations in human cancer and genotype-phenotype correlations. Hum Mol Genet8:2359–2368
    [Google Scholar]
  45. Sevenet N., Sheridan E., Amram D., Schneider P., Handgretinger R., Delattre O.. 1999b; Constitutional mutations of the hSNF5/INI1 gene predispose to a variety of cancers. Am J Hum Genet65:1342–1348
    [Google Scholar]
  46. Shiio Y., Yamamoto T., Yamaguchi N.. 1992; Negative regulation of Rb expression by the p53 gene product. Proc Natl Acad Sci U S A89:5206–5210
    [Google Scholar]
  47. Soulier J., Grollet L., Oksenhendler E., Cacoub P., Cazals-Hatem D., Babinet P., d'Agay M. F., Clauvel J. P., Raphael M., Degos L.. 1995; Kaposi's sarcoma-associated herpesvirus-like DNA sequences in multicentric Castleman's disease. Blood86:276–280
    [Google Scholar]
  48. Sun R., Lin S. F., Gradoville L., Yuan Y., Zhu F., Miller G.. 1998; A viral gene that activates lytic cycle expression of Kaposi's sarcoma-associated herpesvirus. Proc Natl Acad Sci U S A95:10866–10871
    [Google Scholar]
  49. Sun R., Lin S. F., Staskus K., Gradoville L., Grogan E., Haase A., Miller G.. 1999; Kinetics of Kaposi's sarcoma-associated herpesvirus gene expression. J Virol73:2232–2242
    [Google Scholar]
  50. Turelli P., Doucas V., Craig E., Mangeat B., Klages N., Evans R., Kalpana G. V., Trono D.. 2001; Cytoplasmic recruitment of INI1 and PML on incoming HIV preintegration complexes: interference with early steps of viral replication. Mol Cell7:1245–1254
    [Google Scholar]
  51. Versteege I., Sevenet N., Lange J., Rousseau-Merck M., Ambros P., Handgretinger R., Aurias A., Delattre O.. 1998; Truncating mutations of hSNF5/INI1 in aggressive paediatric cancer. Nature394:203–206
    [Google Scholar]
  52. Vignali M., Hassan A. H., Neely K. E., Workman J. L.. 2000; ATP-dependent chromatin-remodeling complexes. Mol Cell Biol20:1899–1910
    [Google Scholar]
  53. Williams S. C., Baer M., Dillner A. J., Johnson P. F.. 1995; CRP2 (C/EBPβ) contains a bipartite regulatory domain that controls transcriptional activation, DNA binding and cell specificity. EMBO J14:3170–3183
    [Google Scholar]
  54. Wu D. Y., Kalpana G. V., Goff S. P., Schubach W. H.. 1996; Epstein–Barr virus nuclear protein 2 (EBNA2) binds to a component of the human SNF–SWI complex, hSNF5/INI1. J Virol70:6020–6028
    [Google Scholar]
  55. Wu D. Y., Krumm A., Schubach W. H.. 2000; Promoter-specific targeting of human SWI–SNF complex by Epstein–Barr virus nuclear protein 2. J Virol74:8893–8903
    [Google Scholar]
  56. Wu F. Y., Ahn J. H., Alcendor D. J., Jang W. J., Xiao J., Hayward S. D., Hayward G. S.. 2001; Origin-independent assembly of Kaposi's sarcoma-associated herpesvirus DNA replication compartments in transient cotransfection assays and association with the ORF-K8 protein and cellular PML. J Virol75:1487–1506
    [Google Scholar]
  57. Yuge M., Nagai H., Uchida T., Murate T., Hayashi Y., Hotta T., Saito H., Kinoshita T.. 2000; hSNF5/INI1 gene mutations in lymphoid malignancy. Cancer Genet Cytogenet122:37–42
    [Google Scholar]
  58. Yung E., Sorin M., Pal A., Craig E., Morozov A., Delattre O., Kappes J., Ott D., Kalpana G. V.. 2001; Inhibition of HIV-1 virion production by a transdominant mutant of integrase interactor 1. Nat Med7:920–926
    [Google Scholar]
  59. Zhu F. X., Cusano T., Yuan Y.. 1999; Identification of the immediate-early transcripts of Kaposi's sarcoma-associated herpesvirus. J Virol73:5556–5567
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/vir.0.18699-0
Loading
/content/journal/jgv/10.1099/vir.0.18699-0
Loading

Data & Media loading...

Most cited this month Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error